MoneyWorks4Me

Lupin informs about unaudited financial results

12 Feb 2025 Evaluate

Pursuant to Regulations 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Lupin has informed that the Board of Directors of the Company, at its meeting held on Tuesday, February 11, 2025, unanimously approved the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2024. The abovesaid Unaudited Financial Results along with the Limited Review Reports of the Statutory Auditors thereon are enclosed. The Board meeting commenced on February 11, 2025, at 09:00 pm (IST) and concluded on February 12, 2025, at 12:10 am (IST).

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1250.00
Cipla 1383.00
Lupin 2060.00
Zydus Lifesciences 1195.20
View more..